BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 38553639)

  • 1. PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment.
    Gao J; Xiong A; Liu J; Li X; Wang J; Zhang L; Liu Y; Xiong Y; Li G; He X
    Cancer Gene Ther; 2024 Mar; ():. PubMed ID: 38553639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis).
    Christgen S; Zheng M; Kesavardhana S; Karki R; Malireddi RKS; Banoth B; Place DE; Briard B; Sharma BR; Tuladhar S; Samir P; Burton A; Kanneganti TD
    Front Cell Infect Microbiol; 2020; 10():237. PubMed ID: 32547960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis).
    Samir P; Malireddi RKS; Kanneganti TD
    Front Cell Infect Microbiol; 2020; 10():238. PubMed ID: 32582562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. It's All in the PAN: Crosstalk, Plasticity, Redundancies, Switches, and Interconnectedness Encompassed by PANoptosis Underlying the Totality of Cell Death-Associated Biological Effects.
    Gullett JM; Tweedell RE; Kanneganti TD
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis).
    Zheng M; Kanneganti TD
    Immunol Rev; 2020 Sep; 297(1):26-38. PubMed ID: 32729116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways.
    Wang Y; Kanneganti TD
    Comput Struct Biotechnol J; 2021; 19():4641-4657. PubMed ID: 34504660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PANoptosis: Mechanisms, biology, and role in disease.
    Sun X; Yang Y; Meng X; Li J; Liu X; Liu H
    Immunol Rev; 2024 Jan; 321(1):246-262. PubMed ID: 37823450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell death shapes cancer immunity: spotlighting PANoptosis.
    Gao L; Shay C; Teng Y
    J Exp Clin Cancer Res; 2024 Jun; 43(1):168. PubMed ID: 38877579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hierarchical Cell Death Program Disrupts the Intracellular Niche Required for Burkholderia thailandensis Pathogenesis.
    Place DE; Christgen S; Tuladhar S; Vogel P; Malireddi RKS; Kanneganti TD
    mBio; 2021 Jun; 12(3):e0105921. PubMed ID: 34154417
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes.
    Pandeya A; Kanneganti TD
    Trends Mol Med; 2024 Jan; 30(1):74-88. PubMed ID: 37977994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PANoptosis: Emerging mechanisms and disease implications.
    Qi Z; Zhu L; Wang K; Wang N
    Life Sci; 2023 Nov; 333():122158. PubMed ID: 37806654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immune inflammatory cell death: PANoptosis and PANoptosomes in host defense and disease.
    Chen W; Gullett JM; Tweedell RE; Kanneganti TD
    Eur J Immunol; 2023 Nov; 53(11):e2250235. PubMed ID: 36782083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PANoptosis: a potential new target for programmed cell death in breast cancer treatment and prognosis.
    Liu X; Miao M; Sun J; Wu J; Qin X
    Apoptosis; 2024 Apr; 29(3-4):277-288. PubMed ID: 38001342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of PANoptosis in cancer treatment.
    Xiong Y
    Biomed Pharmacother; 2023 Dec; 168():115696. PubMed ID: 37837884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune regulator IRF1 contributes to ZBP1-, AIM2-, RIPK1-, and NLRP12-PANoptosome activation and inflammatory cell death (PANoptosis).
    Sharma BR; Karki R; Rajesh Y; Kanneganti TD
    J Biol Chem; 2023 Sep; 299(9):105141. PubMed ID: 37557956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PANoptosis: A Cell Death Characterized by Pyroptosis, Apoptosis, and Necroptosis.
    Shi C; Cao P; Wang Y; Zhang Q; Zhang D; Wang Y; Wang L; Gong Z
    J Inflamm Res; 2023; 16():1523-1532. PubMed ID: 37077221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed Cell Death Tunes Tumor Immunity.
    Liu J; Hong M; Li Y; Chen D; Wu Y; Hu Y
    Front Immunol; 2022; 13():847345. PubMed ID: 35432318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase-6 is a key regulator of cross-talk signal way in PANoptosis in cancer.
    Qi L; Wang L; Jin M; Jiang M; Li L; Li Y
    Immunology; 2023 Jul; 169(3):245-259. PubMed ID: 36814103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspase-Linked Programmed Cell Death in Prostate Cancer: From Apoptosis, Necroptosis, and Pyroptosis to PANoptosis.
    Zhu M; Liu D; Liu G; Zhang M; Pan F
    Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PANoptosis in cancer, the triangle of cell death.
    Cai H; Lv M; Wang T
    Cancer Med; 2023 Dec; 12(24):22206-22223. PubMed ID: 38069556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.